+------------------------------------------------------------------------------+
Pfizer’s Biggest 25 Holders Own More Than 37% of AstraZeneca 2014-05-09 12:36:09.757 GMT
By Allison Connolly and Gaurav Panchal May 9 (Bloomberg) -- Pfizer’s top 25 shareholders own 37.14% of its takeover target AstraZeneca, which has rejected the cash & shares offers twice, based on Bloomberg data. * AstraZeneca is meeting with shareholders this week, while Pfizer sees backlash by Congress, States for its bid
Top Shareholders: Bloomberg data * AstraZeneca: Blackrock 7.75%, AXA 5.45%, Wellington 5.18%, Vanguard 4.79%, Investor AB 4.1%, Invesco 3.7%, Legal & General Group 3.45%, Capital Group 2.86%, State Street 2.8%, Aberdeen 2.39% * On May 6, Investor AB supported rejection of bid * Pfizer: Vanguard 6.91%, Blackrock 6.75%, State Street 4.15%, Capital Group 2.33%, Bank of NY Mellon 1.78%, Northern Trust Corp. 1.55%, Wellington 1.54%, Franklin Resources 1.42%, Massachusetts Financial 1.32%, T. Rowe Price 1.29%
AstraZeneca Ownership Breakdown: * Geography: U.S. 46.08%, U.K. 24.88%, Sweden 5.78%, Ireland 5.46%, France 4.81%, Norway 2.16% * Type: Investment Advisor 85.63%, Govt 4.22%, Banks 3.65%, Pension Fund 2.25%
Short Interest: Markit * AstraZeneca has 0.6% of shares outstanding vs 52-wk high of 0.73% in Dec., 1.9 days to cover vs 52-wk. high of 4.49 in Dec.
Key dates: * May 13: U.K. business secretary Vince Cable faces lawmakers’ questions; AstraZeneca, Pfizer CEOs appear before Business, Innovation and Skills Committee * May 14: AstraZeneca, Pfizer CEOs appear before Science and Technology Committee May 26: Deadline for Pfizer bid, extendable
NOTES: * On May 2: AstraZeneca said Pfizer’s second proposal was inadequate, undervalued company; rejected offer was 1.845 PFE shares plus 1,598p cash for each Astra share * Inital April 28 rejected proposal was 1.758 Pfizer shares, 1,398p cash * Earlier: AstraZeneca investors put money on Pfizer bid bump
For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>
To contact the reporters on this story: Allison Connolly in London at +44-20-3525-7043 or aconnolly4@bloomberg.net; Gaurav Panchal in London at +44-20-7392-0511 or gpanchal2@bloomberg.net To contact the editors responsible for this story: James Ludden at +44-20-7673-2645 or jludden@bloomberg.net Gaurav Panchal